Doctor profile · Federal record

Dr. Antoinette Matthews, M.D.

Hematology & Oncology Physician (CMS: Hematology/Oncology) · Internal Medicine Physician · Internal Medicine Physician · Dallas, TX

  • NPI 1831577436
  • Accepts Medicare
  • MIPS 86.7 / 100 · 2023
  • 11 yrs in practice
  • Female
  • Solo practice
  • No sanctions

Practice & contact

Operates at 2 locations .

NPPES Updated May 11, 2026
Primary practice
3410 Worth Street, Suite 400
Dallas, TX 75246
(214) 370-1000
fax (214) 370-1986
Additional location
3501 Junius Street
Dallas, TX 75246
(214) 208-3151
Mailing address
Po Box 911230
Dallas, TX 753911230

Credentials & registration

NPPES · NUCC
NPI registered
May 2015 — 11 yrs on file
Profile last updated
May 10, 2022
Year of graduation
2015 — 11 yrs since
Specialty taxonomy
207RH0003X — NUCC code
State licenses (2)
Texas #R1415 · Texas #TBD
Medicaid
TX #426382401

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1831577436. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
28,805
Distinct HCPCS
10
Medicare allowed
$607,857
HCPCS Description Services Patients Avg allowed
J9271 Injection, pembrolizumab, 1 mg 8,400 33 $54
J1453 Injection, fosaprepitant, 1 mg 6,750 42 $0
J9267 Injection, paclitaxel, 1 mg 4,914 23 $0
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 3,588 40 $0
J1100 Injection, dexamethasone sodium phosphate, 1 mg 1,095 81 $0
J2469 Injection, palonosetron hcl, 25 mcg 660 54 $1
J1626 Injection, granisetron hydrochloride, 100 mcg 510 34 $0
99214 Established patient office or other outpatient visit, 30-39 minutes 287 147 $127
J9201 Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg 250 17 $4
36415 Insertion of needle into vein for collection of blood sample 219 56 $8

In context: peer comparison

Among 40 peers in Dallas Hematology & Oncology Physician, average services per provider: 813. This provider delivers 35× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$2,328
Transactions
71
Manufacturers
10
Payer (manufacturer) Industry Txns Amount
Novartis Pharmaceuticals Corporation 13 $1,023.75
AstraZeneca Pharmaceuticals Lp 16 $440.51
Daiichi Sankyo INC. 17 $420.13
Stemline Therapeutics INC. 12 $181.09
Merck Sharp & Dohme LLC 4 $96.97
Genentech USA, INC. 3 $45.34
Gilead Sciences, INC. 2 $39.52
Tempus Ai, INC 2 $38.07
Regeneron Healthcare Solutions, INC. 1 $22.39
Sobi, INC 1 $20.30

By nature of payment

Food and Beverage
$1,228
Long Term Medical Supply or Device Loan
$1,000
Education
$100

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
742
Patients
189
Total drug cost
$1,264,523
Drug Type Claims Patients Total cost
Letrozole Generic 261 84 $7,907
Tamoxifen Citrate Generic 189 60 $5,354
Anastrozole Generic 86 32 $2,338
Verzenio (Abemaciclib) Brand 33 0 $520,218
Exemestane Generic 31 13 $7,532
Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) Brand 19 0 $364
Ibrance (Palbociclib) Brand 19 0 $312,842
Dexamethasone Generic 15 0 $164
Gabapentin Generic 15 0 $142
Ondansetron Odt (Ondansetron) Brand 15 0 $175

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Antoinette Matthews's medical specialty?
Dr. Antoinette Matthews practices Hematology & Oncology Physician in Dallas, TX.
Where does Dr. Antoinette Matthews practice?
Dr. Antoinette Matthews practices at 3410 Worth Street, Suite 400, Dallas, TX 75246. Office phone: 2143701000.
What is Dr. Antoinette Matthews's NPI?
Dr. Antoinette Matthews's National Provider Identifier (NPI) is 1831577436, issued by NPPES.
Does Dr. Antoinette Matthews accept Medicare assignment?
Yes. Dr. Antoinette Matthews accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Antoinette Matthews commonly perform?
Top Medicare-reported procedures in 2023: Injection, pembrolizumab, 1 mg (HCPCS J9271); Injection, fosaprepitant, 1 mg (HCPCS J1453); Injection, paclitaxel, 1 mg (HCPCS J9267). Source: CMS Medicare Physician & Other Practitioners file.